Concord Drugs Ltd — Important, 10-04-2026: Company Update

Concord Drugs Limited has submitted a compliance certificate from its Registrar and Share Transfer Agent, Aarthi Consultants Private Limited. The certificate confirms that for the quarter ended March 31, 2026, all dematerialization requests were processed in accordance with regulations. This included ensuring dematerialized securities are listed on exchanges, physical certificates were mutilated and cancelled, and the depository's name was updated as the registered owner. This is a routine but important update, confirming the smooth and compliant handling of investor share conversions from physical to electronic form, crucial for market efficiency and shareholder confidence.